Chengwen Sun

No. 1000, Hefeng Road
Wuxi, 214000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Platycodin D-mediated METTL16 downregulation promotes docetaxel treatment of prostate cancer by regulating ferroptosis.

Platycodin D-mediated METTL16 downregulation promotes docetaxel treatment of prostate cancer by regulating ferroptosis.

Journal: BMC cancer

Published: September 20, 2024

Hsa_circ_0030568 Promotes the Proliferation and Migration of Prostate Cancer Cells via the miR-141-3p-BRD4 Axis.

Hsa_circ_0030568 Promotes the Proliferation and Migration of Prostate Cancer Cells via the miR-141-3p-BRD4 Axis.

Journal: Combinatorial chemistry & high throughput screening

Published: September 10, 2024

Preliminary evaluation of a novel PSMA-targeting radiopharmaceutical [68Ga]Ga/[177Lu]Lu-NYM032 for theranostic use in prostate cancer.

Preliminary evaluation of a novel PSMA-targeting radiopharmaceutical [68Ga]Ga/[177Lu]Lu-NYM032 for theranostic use in prostate cancer.

Journal: European journal of nuclear medicine and molecular imaging

Published: September 08, 2024

Anti-cancer role of curcumin in prostate cancer cells via regulation of m6A-modified circ0030568-FMR1 signaling pathway.

Anti-cancer role of curcumin in prostate cancer cells via regulation of m6A-modified circ0030568-FMR1 signaling pathway.

Journal: Translational andrology and urology

Published: June 07, 2024

A tumour-associated macrophage-based signature for deciphering prognosis and immunotherapy response in prostate cancer.

A tumour-associated macrophage-based signature for deciphering prognosis and immunotherapy response in prostate cancer.

Journal: IET systems biology

Published: February 23, 2024

Modified the 8th AJCC staging system for patients with advanced prostate cancer: a study based on SEER database.

Modified the 8th AJCC staging system for patients with advanced prostate cancer: a study based on SEER database.

Journal: BMC urology

Published: April 29, 2022

Sialidase NEU1 suppresses progression of human bladder cancer cells by inhibiting fibronectin-integrin α5β1 interaction and Akt signaling pathway.

Sialidase NEU1 suppresses progression of human bladder cancer cells by inhibiting fibronectin-integrin α5β1 interaction and Akt signaling pathway.

Journal: Cell communication and signaling : CCS

Published: October 29, 2019

miR‑486 acts as an oncogene and potential prognostic biomarker in renal cell carcinoma.

miR‑486 acts as an oncogene and potential prognostic biomarker in renal cell carcinoma.

Journal: Molecular medicine reports

Published: November 14, 2018

Quantitative Analysis of Differential Proteome Expression in Epithelial-to-Mesenchymal Transition of Bladder Epithelial Cells Using SILAC Method.

Quantitative Analysis of Differential Proteome Expression in Epithelial-to-Mesenchymal Transition of Bladder Epithelial Cells Using SILAC Method.

Journal: Molecules (Basel, Switzerland)

Published: November 12, 2015

Quantitative Analysis of Differential Proteome Expression in Bladder Cancer vs. Normal Bladder Cells Using SILAC Method.

Quantitative Analysis of Differential Proteome Expression in Bladder Cancer vs. Normal Bladder Cells Using SILAC Method.

Journal: PloS one

Published: January 20, 2015

Quantitative glycome analysis of N-glycan patterns in bladder cancer vs normal bladder cells using an integrated strategy.

Quantitative glycome analysis of N-glycan patterns in bladder cancer vs normal bladder cells using an integrated strategy.

Journal: Journal of proteome research

Published: December 24, 2014

Showing 1-11 of 11

Last Updated: 09/26/2026